Clinical Trials Logo
  1. Home
  2. Stone, Kidney
  3. NCT06381206
  4. Details
NCT06381206 Clinical Trial

Silodosin in Management of Lower Ureteral Stones

Stone, Kidney Clinical Trial

Official title:
The Use of Selective Alpha Blockers (Silodosin) in Management of Lower Ureteral Stones Larger Than 6 mm in Diameter

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06381206
Other study ID # No 475
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date October 20, 2022
Est. completion date October 25, 2023

Study information
Verified date April 2024
Source Syrian Private University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date October 25, 2023
Est. primary completion date October 20, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Patients attending the urology Clinic with a distal unilateral ureteral stone larger than 6 mm in diameter. Exclusion Criteria: - Patients under 18 years of age - Pregnant women - Patients with whom we were unable to contact - Patients treated with silodosin for another reason - Single kidney patients - Patients with bilateral ureter stones - Patients with deteriorating kidney function - Patients with grades 3rd and 4th of hydronephrosis

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Silodosin
Selective Alpha Blocker drug

Locations
Country Name City State
Syrian Arab Republic Damascus university Damascus

Sponsors (1)
Lead Sponsor Collaborator
Syrian Private University

Country where clinical trial is conducted

Syrian Arab Republic, 

Outcome
Type Measure Description Time frame Safety issue
Primary Stone expulsion (yes) patients who were able to expel the stone 1 year
Primary Stone expulsion (no) patients who were not able to expel the stone 1 year
See also
  Status Clinical Trial Phase
Completed NCT05340075 - Staged Bilateral Percutaneous Nephrolithotomy
Completed NCT05340088 - Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Completed NCT05183269 - Virtual Reality for Pain Control During Extracorporeal Shock Wave Lithotripsy: a Prospective, Comparative, Randomized Study at a Single Institution N/A
Completed NCT05646069 - Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi N/A
Completed NCT05413603 - Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization N/A
Enrolling by invitation NCT06394908 - Registry of MIUS for Urolithiasis (ReMIUS-U)
Recruiting NCT05535816 - Accuracy of Ultrasound for Detecting Residual Fragments During RIRS N/A
Recruiting NCT05460559 - Endoscopic Combined Intrarenal Surgery Versus Multi-Tract Percutaneous Nephrolithotomy for Complex Renal Stones: N/A
Completed NCT03567421 - Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
Recruiting NCT05866081 - Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative N/A
Completed NCT04594161 - Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis N/A
Not yet recruiting NCT03771365 - Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone
Recruiting NCT04764071 - Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial. Phase 3
Completed NCT06031103 - Clinical Efficacy of Mini-PCNLversus RIRS for the Management of Upper Urinary Tract Calculus (1-2.5 cm) N/A
Active, not recruiting NCT05759767 - The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis N/A
Not yet recruiting NCT04650737 - Single-Shot With Dexmedetomidine Versus Continuous Ultrasound-guided Erector Spinae Plane Block for Postoperative Pain Control After Percutaneous Nephrolithotomy N/A
Active, not recruiting NCT05389982 - Mobile Health Platform for Surveillance of Kidney Stone N/A
Completed NCT03388060 - (SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone N/A